ARTICLE | Financial News

AC Immune sets IPO terms

September 13, 2016 7:00 AM UTC

AC Immune S.A. (Lausanne, Switzerland) amended its proposed IPO on NASDAQ and now plans to sell 4.5 million shares at $11-$13. At $12, the company would raise $54.5 million and be valued at $647.3 million. Credit Suisse, Jefferies and Leerink are underwriters.

In May, the company proposed to raise up to $50 million via the listing. ...